NeoGenomics Reports 51% Revenue Growth to Record $96 Million in the First Quarter
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil pares losses as market weighs Saudi supply concerns, Middle East tensions
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
NeoGenomics (NEO) Tops Q1 EPS by 3c
April 30, 2019 8:14 AM EDTNeoGenomics (NASDAQ: NEO) reported Q1 EPS of $0.07, $0.03 better than the analyst estimate of $0.04. Revenue for the quarter came in at $95.6 million versus the consensus estimate of $90.61 million.
GUIDANCE:
NeoGenomics sees FY2019 revenue of $384-400 million, versus the consensus of $385... More
